Nycomed has compiled an impressive track record in research in Canada. Over the past 12 years, our company has been involved with approximately 50 clinical trials, enrolling more than 10,150 patients at 900 sites. We have just initiated a Phase IV trial that will include more than 2,000 patients from approximately 200 sites.
Nycomed actively supports the objective of discovering new medicines that improve the quality of health care for every Canadian.